Rushnet, Inc. and its Subsidiaries Persist in the Climb Towards its Major Milestones and Goals
ALPHARETTA, GA / ACCESSWIRE / April 6, 2022 / Rushnet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce an...
Month: April 2022
Claim.MD Achieves CORE Certification on Eligibility & Benefits, Claim Status and Payment & Remittance Rules
Demonstrates Commitment to Streamlining Healthcare Revenue CyclePECOS, NM / ACCESSWIRE / April 6, 2022 / Claim.MD, a leading electronic data...
Neuropathix, Inc. CEO Issues New Letter to Shareholders; Updates Market on Milestones in Research and Funding
DOYLESTOWN, PA / ACCESSWIRE / April 6, 2022 / Neuropathix, Inc. ("Neuropathix" or the "Company") (OTCQB:NPTX), a socially responsible pain...
Article “Novel Cannabidiol Aspartame Combination Treatment (JW-100) Significantly Reduces ISGA Score in Atopic Dermatitis: Results From a Randomized Double-Blinded Placebo-Controlled Interventional Study” Published in Journal of Cosmetic Dermatology
Authored by an International Group of Leading Dermatology Researchers and Clinicians Who Conducted the StudiesJUPITER, FL / ACCESSWIRE / April...
Jaguar Animal Health to Host Dinner & Tableside Discussion for U.S. Veterinary Oncologists About Chemotherapy-Induced Diarrhea (CID) in Dogs on April 12th, the Final Day of the Veterinary Cancer Society (VCS) Mid-Year Conference in Puerto Vallarta, Mexico
Canalevia™-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for CID...
Novamind Opens 8th Integrative Psychiatry Clinic
New clinic in Phoenix, AZ, offers innovative mental health treatments and group therapyTORONTO, ON / ACCESSWIRE / April 6, 2022...
Revelation Biosciences Inc. Announces Conference Call to Provide a Corporate Update
-CLEAR Study enrollment ongoing top-line data expected 2H 2022- -Diagnostic partnering discussions ongoing- SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE)...
Progenity Announces Two Poster Presentations at Controlled Release Society 2022
SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of...
Updated Financial Calendar for 2022
Orphazyme A/S in restructuringCompany announcement No. 19/2022 www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, April 6, 2022 – Orphazyme A/S...
Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate of Free Sale with Daily and Acute Dosing on the Label
New York, NY, and Tel Aviv, ISRAEL, April 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive...
Pure Extracts Ships Repeat Orders of Vape Cartridges and Edibles to Alberta
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
INT301 Continues to Meet Safety Goals in Phase 1 OMEGA Study in Adults with Peanut Allergy While Reaching Phase 2 Target Maintenance Dose
INT301 Met Safety Goals Across Eleven Dose Levels Patient Treatment Now Ongoing in Cohort 3 Intrommune Expands Study Scope to...
Celsion and Medidata to Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial
Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients to be presented at 2022 AACR Annual...
Day One to Present at the 21st Annual Needham Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated...
Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting
SALT LAKE CITY, April 06, 2022 (GLOBE NEWSWIRE) -- Stella Diagnostics, Inc. (OTC: SLDX), a molecular diagnostics-based organization optimizing patient...
Core One Labs’ Upgrades to OTCQB Venture Market
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: “COOL”), (OTCQB: “CLABF”), (Frankfurt: LD6, WKN:...
Biofrontera Inc. Announces Preliminary Product Revenues for the First Quarter of 2022
WOBURN, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...
CELSION CORPORATION ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
LAWRENCEVILLE, NJ, April 06, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into...
Bazelet Health announces PECSA™, its new federally legal, non-GMO plant-based cannabis ingredient for US and export markets
COLUMBIA, Md., April 06, 2022 (GLOBE NEWSWIRE) -- Neon Bloom Inc. (OTC: NBCO) -- Bazelet Health Systems, Inc. (Bazelet™), a wholly...
Akoya Biosciences to Showcase New Data on PhenoCycler-Fusion at the AACR Annual Meeting 2022
Company to present industry’s first 100-plex, whole slide dataset for deep spatial phenotyping of the tumor microenvironmentThe Company will also...